Tiny Biotech Just Beat AbbVie's Drug: Risk for Investors?
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Explore the question of which is better for daily expenses: cash back or points. Make informed choices to maximize your rewards potential.
27,346 articlesA tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
A Detroit autoworker’s dream of winning margins meets a global market that’s increasingly dependent on China. This ar...
Gold Exposure through the SPDR Gold ETF can anchor a diversified portfolio. This article explains why SPDR Gold Been ...
SoFi's Mastercard collaboration could unlock more than just card revenue. This article explains why the deal might ex...
A major institutional bet lands on Birkenstock. Rice Hall James loads 466,577 shares, a roughly $19.8 million stake i...
As AI infrastructure spending accelerates, legendary short seller chanos cautions that the rally could follow a dot-c...
Morgan Stanley elevates Rocket Lab's bull-case to $293, underscoring potential upside even as the stock retreats in a...
Geopolitical tensions lift risk-off pressure on crypto markets, sending btc, eth, and XRP lower as Trump condemns Isr...
A billionaire places a bold personal bet on a private space company. This article breaks down what that move means fo...
Palantir emphasizes software-driven AI workflows with an asset-light model, while Oracle bets on cloud-scale GPU depl...
A fresh oil scare near global chokepoints spurred a quick risk-off mood, sending Bitcoin lower before crypto traders ...
The idea of a sweeping Sell America trade captured headlines for years. This article breaks down what happened, why i...